These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11433889)

  • 21. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
    Flechtner I; de Lonlay P; Polak M
    Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes.
    Holstein A; Hahn M; Stumvoll M; Kovacs P
    Horm Metab Res; 2009 May; 41(5):387-90. PubMed ID: 19214942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14,237 patients with type 2 diabetes mellitus enrolled in 42 short-term, double-blind, randomized clinical studies with rosiglitazone.
    Cobitz A; Zambanini A; Sowell M; Heise M; Louridas B; McMorn S; Semigran M; Koch G
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):769-81. PubMed ID: 18613278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulphonylureas--action and uses.
    Ferrier TM
    Aust Fam Physician; 1976 Jul; 5(6):865-6. PubMed ID: 999566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin.
    Tentolouris N; Matsagura M; Psallas M; Chatzizacharias A; Fotia M; Arvanitis M; Katsilambros N
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):298-301. PubMed ID: 15926117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A lion in the room: Has the CAROLINA trial definitely resolved the issue of the cardiovascular safety of sulfonylureas?
    Koufakis T; Dimitriadis G; Kotsa K
    J Diabetes; 2020 Jul; 12(7):499-502. PubMed ID: 32202061
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulfonylureas and ischemic heart disease.
    Matz R
    Arch Intern Med; 1998 Feb; 158(4):411-2. PubMed ID: 9487240
    [No Abstract]   [Full Text] [Related]  

  • 28. Coronary heart disease outcomes in patients receiving antidiabetic agents.
    McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.
    Hassouna A; Loubani M; Matata BM; Fowler A; Standen NB; Galiñanes M
    Cardiovasc Res; 2006 Feb; 69(2):450-8. PubMed ID: 16330008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
    Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Acta Diabetol; 2009 Jun; 46(2):145-54. PubMed ID: 19194648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes.
    McGuire DK; Newby LK; Bhapkar MV; Moliterno DJ; Hochman JS; Klein WW; Weaver WD; Pfisterer M; Corbalán R; Dellborg M; Granger CB; Van De Werf F; Topol EJ; Califf RM;
    Am Heart J; 2004 Feb; 147(2):246-52. PubMed ID: 14760321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
    Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
    Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supratherapeutic doses of sulfonylureas in diabetic patients: how much is too much?
    Cantrell FL; Clark RF
    Clin Toxicol (Phila); 2007; 45(5):482-4. PubMed ID: 17503251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
    Tawfik MK; Abo-Elmatty DM; Ahmed AA
    Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides.
    Mannucci E; Monami M; Masotti G; Marchionni N
    Diabetes Metab Res Rev; 2004; 20(1):44-7. PubMed ID: 14737744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
    Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
    Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.
    Almdal T; Scharling H; Jensen JS; Vestergaard H
    Arch Intern Med; 2004 Jul; 164(13):1422-6. PubMed ID: 15249351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris.
    Hueb W; Uchida AH; Gersh BJ; Betti RT; Lopes N; Moffa PJ; Ferreira BM; Ramires JA; Wajchenberg BL
    Coron Artery Dis; 2007 Feb; 18(1):55-9. PubMed ID: 17172931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in the treatment of diabetic patients with ischemic cardiopathy].
    Gaxiola-López E; Eng-Ceceña L
    Arch Cardiol Mex; 2002; 72 Suppl 1():S69-75. PubMed ID: 12001874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.